Skip to Content

Label Changes for:

Abilify Discmelt (aripiprazole) Orally Disintegrating Tablets

May 2008

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- May 2008


The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.

Summary View

Sections Modified


  • Drugs Having No Clinically Important Interactions with Abilify
    • Lamotrigine

Label approved 05/06/2008 is not available on Drugs@FDA